Yan Zhou1, Ted Huang2, Francis Lee2, Mary Jeanne Kreek1. 1. Laboratory of the Biology of Addictive Diseases , The Rockefeller University, New York, New York. 2. Department of Psychiatry , Weill Cornell Medical Center, New York, New York.
Abstract
BACKGROUND: The endocannabinoid system has been found to play an important role in modulating alcohol intake. Inhibition or genetic deletion of fatty acid amide hydrolase (FAAH; a key catabolic enzyme for endocannabinoids) leads to increased alcohol consumption and preference in rodent models. A common human single-nucleotide polymorphism (SNP; C385A, rs324420) in the FAAH gene is associated with decreased enzymatic activity of FAAH, resulting in increased anandamide levels in both humans and FAAH C385A knock-in mice. METHODS: As this FAAH SNP has been reported to be associated with altered alcohol abuse, the present study used these genetic knock-in mice containing the human SNP C385A to determine the impact of variant FAAH gene on alcohol "binge" drinking in the drinking-in-the-dark (DID) model. RESULTS: We found that the FAAH(A/A) mice had greater alcohol intake and preference than the wild-type FAAH(C/C) mice, suggesting that increased endocannabinoid signaling in FAAH(A/A) mice led to increased alcohol "binge" consumption. The specificity on alcohol vulnerability was suggested by the lack of any FAAH genotype difference on sucrose or saccharin intake. Using the "binge" DID model, we confirmed that selective CB1 receptor antagonist AM251 reduced alcohol intake in the wild-type mice. CONCLUSIONS: These data suggest that there is direct and selective involvement of the human FAAH C385A SNP and CB1 receptors in alcohol "binge" drinking.
BACKGROUND: The endocannabinoid system has been found to play an important role in modulating alcohol intake. Inhibition or genetic deletion of fatty acid amide hydrolase (FAAH; a key catabolic enzyme for endocannabinoids) leads to increased alcohol consumption and preference in rodent models. A common human single-nucleotide polymorphism (SNP; C385A, rs324420) in the FAAH gene is associated with decreased enzymatic activity of FAAH, resulting in increased anandamide levels in both humans and FAAH C385A knock-in mice. METHODS: As this FAAH SNP has been reported to be associated with altered alcohol abuse, the present study used these genetic knock-in mice containing the human SNP C385A to determine the impact of variant FAAH gene on alcohol "binge" drinking in the drinking-in-the-dark (DID) model. RESULTS: We found that the FAAH(A/A) mice had greater alcohol intake and preference than the wild-type FAAH(C/C) mice, suggesting that increased endocannabinoid signaling in FAAH(A/A) mice led to increased alcohol "binge" consumption. The specificity on alcohol vulnerability was suggested by the lack of any FAAH genotype difference on sucrose or saccharin intake. Using the "binge" DID model, we confirmed that selective CB1 receptor antagonist AM251 reduced alcohol intake in the wild-type mice. CONCLUSIONS: These data suggest that there is direct and selective involvement of the humanFAAH C385A SNP and CB1 receptors in alcohol "binge" drinking.
Authors: B F Cravatt; K Demarest; M P Patricelli; M H Bracey; D K Giang; B R Martin; A H Lichtman Journal: Proc Natl Acad Sci U S A Date: 2001-07-24 Impact factor: 11.205
Authors: Giancarlo Colombo; Salvatore Serra; Giovanni Vacca; Mauro A M Carai; Gian Luigi Gessa Journal: Pharmacol Biochem Behav Date: 2005-06 Impact factor: 3.533
Authors: Balapal S Basavarajappa; Ratnakumar Yalamanchili; Benjamin F Cravatt; Thomas B Cooper; Basalingappa L Hungund Journal: Neuropharmacology Date: 2006-01-30 Impact factor: 5.250
Authors: D Proudnikov; T Kroslak; J C Sipe; M Randesi; D Li; S Hamon; A Ho; J Ott; M J Kreek Journal: Pharmacogenomics J Date: 2009-12-15 Impact factor: 3.550
Authors: Jack C Sipe; Kyle Chiang; Alexandra L Gerber; Ernest Beutler; Benjamin F Cravatt Journal: Proc Natl Acad Sci U S A Date: 2002-06-11 Impact factor: 11.205
Authors: Matthew E Sloan; Joshua L Gowin; Jia Yan; Melanie L Schwandt; Primavera A Spagnolo; Hui Sun; Colin A Hodgkinson; David Goldman; Vijay A Ramchandani Journal: Addict Biol Date: 2017-02-01 Impact factor: 4.280
Authors: Yan Zhou; Benjamin I Schwartz; Joanna Giza; Steven S Gross; Francis S Lee; Mary Jeanne Kreek Journal: Psychopharmacology (Berl) Date: 2017-07-20 Impact factor: 4.530
Authors: Elena V Feofanova; Han Chen; Yulin Dai; Peilin Jia; Megan L Grove; Alanna C Morrison; Qibin Qi; Martha Daviglus; Jianwen Cai; Kari E North; Cathy C Laurie; Robert C Kaplan; Eric Boerwinkle; Bing Yu Journal: Am J Hum Genet Date: 2020-10-07 Impact factor: 11.025
Authors: Laura M Best; Belinda Williams; Bernard Le Foll; Esmaeil Mansouri; Richard P Bazinet; Lin Lin; Vincenzo De Luca; Dina Lagzdins; Pablo Rusjan; Rachel F Tyndale; Alan A Wilson; Christian S Hendershot; Markus Heilig; Sylvain Houle; Junchao Tong; Stephen J Kish; Isabelle Boileau Journal: Neuropsychopharmacology Date: 2020-01-07 Impact factor: 7.853
Authors: Olga Seleverstov; Ana Tobiasz; J Scott Jackson; Ryan Sullivan; Dejian Ma; J Pierce Sullivan; Steven Davison; Yada Akkhawattanangkul; Danielle L Tate; Terry Costello; Stacey Barnett; Wei Li; Giancarlo Mari; Alex M Dopico; Anna N Bukiya Journal: Alcohol Date: 2017-05-18 Impact factor: 2.405